Chemomab Therapeutics Ltd.
CMMB
$1.74
-$0.03-1.70%
NASDAQ
| 12/31/2025 | 06/30/2025 | 12/31/2024 | 09/30/2024 | 03/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -27.34% | -26.42% | -27.89% | -9.33% | -43.03% |
| Total Receivables | -25.86% | 68.35% | -9.00% | -52.39% | -48.55% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 99.58% | -- | 91.84% | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | 100.00% | 0.00% | 4.17% | -- |
| Total Current Assets | -16.30% | -21.11% | -23.24% | -11.06% | -43.08% |
|
|
|||||
| Total Current Assets | -16.30% | -21.11% | -23.24% | -11.06% | -43.08% |
| Net Property, Plant & Equipment | -67.35% | -64.83% | -22.45% | 28.51% | -18.29% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -45.19% | -36.86% | -31.13% | -29.02% | -27.29% |
| Total Assets | -18.58% | -23.48% | -23.42% | -10.77% | -42.56% |
|
|
|||||
| Total Accounts Payable | -23.38% | -66.04% | 22.67% | -47.20% | 49.09% |
| Total Accrued Expenses | -59.80% | -65.91% | -41.83% | -15.06% | 143.73% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | 51.32% | 6.67% | -0.86% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | -54.07% | -66.81% | -33.48% | -19.01% | 98.95% |
|
|
|||||
| Total Current Liabilities | -54.07% | -66.81% | -33.48% | -19.01% | 98.95% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -33.86% | 4,500.00% | -69.46% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -56.87% | -68.63% | -33.51% | -14.81% | 89.76% |
|
|
|||||
| Common Stock & APIC | 6.71% | 10.87% | 9.92% | 11.64% | 3.28% |
| Retained Earnings | -8.77% | -12.30% | -15.73% | -17.77% | -75.82% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -8.89% | -2.86% | -20.36% | -9.56% | -51.16% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -8.89% | -2.86% | -20.36% | -9.56% | -51.16% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -8.89% | -2.86% | -20.36% | -9.56% | -51.16% |
|
|
|||||